Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial

CONTEXT: The effect of the anti-inflammatory and immunomodulatory actions of vitamin D on the duration of partial clinical remission (PR) in youth with type 1 diabetes (T1D) is unclear. OBJECTIVE: This work aimed to determine the effect of adjunctive ergocalciferol on residual β-cell function (RBCF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwosu, Benjamin Udoka, Parajuli, Sadichchha, Jasmin, Gabrielle, Fleshman, Jody, Sharma, Rohit B, Alonso, Laura C, Lee, Austin F, Barton, Bruce A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668202/
https://www.ncbi.nlm.nih.gov/pubmed/34913020
http://dx.doi.org/10.1210/jendso/bvab179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668202/
https://www.ncbi.nlm.nih.gov/pubmed/34913020
http://dx.doi.org/10.1210/jendso/bvab179

Ejemplares similares